Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma

Immunology

Volumn 92, Issue 1, 1997, Pages 99-103

  Di Renzo, M ^a   Rubegni, P ^a   De Aloe, G ^a   Paulesu, L ^a   Pasqui, A L ^a   Andreassi, L ^a   Auteri, A ^a   Fimiani, M ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; METHOXSALEN; PHYTOHEMAGGLUTININ;

ADULT; AGED; ARTICLE; CANCER STAGING; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY CANCER; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE ACTIVATION; MALE; MONONUCLEAR CELL; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; SKIN LYMPHOMA; T CELL LYMPHOMA;

EID: 0030768336     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.00325.x     Document Type: Article

References (32)

1. HOLLOWAY B.H., FLOWERES P.F. & RAMOS-CARO F.A. (1992) Therapeutic alternatives in cutaneous T-cell lymphoma. J Am Acad Dermatol 27, 367.
2. HEALD P., ROOK A. & PEREZ M. (1992) Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy. J Am Acad Dermatol 127, 427.
3. EDELSON R., BERGER C. & GASPARRO F. (1987) Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. N Engl J Med 316, 297.
4. FIMIANI M., RUBEGNI P., D'ASCENZO G. & ANDREASSI L. (1994) Extracorporeal photochemotherapy in the early treatment of cutaneous T-cell lymphoma. J Am Acad Dermatol 31, 828.
5. KHAVARI P.A., EDELSON R.L. & LIDER O. (1988) Specific vaccination against photoinactivated cloned T cells. Clin Res 36, 662.
6. PEREZ M., EDELSON R.L. & LAROCHE L. (1989) Specific suppression of antiallograft immunity by immunization with syngenic photoinactivated effector lymphocytes. J Invest Dermatol 92, 669.
7. EDELSON R.L. (1990) Photopheresis. J Clin Apheresis 5, 77.
8. EDELSON R.L. (1991) Photopheresis: a clinically relevant immunobiologic modifier. Ann NY Acad Sci 636, 154.
9. VOWELS B.R., CASSIN M., BOUFAL M.H. et al. (1992) Extracorporeal photochemotherapy induces the production of tumor necrosis factor-α by monocytes: implication for the treatment of cutaneous T-cell lymphoma and systemic sclerosis. J Invest Dermatol 122, 686.
10. + circulating monocytes in patients with mycosis fungoides. Dermatology 194, 107.
11. ROOK A. H., VOWELS B. R., JAWORSKY C. et al. (1993) The immunopathogenesis of cutaneous T-cell lymphoma. Arch Dermatol 129, 486.
12. LAROCHE L. & KAISERLIAN D. (1983) Decreased natural-killer activity in cutaneous T-cell lymphomas. N Engl J Med 308, 101.
13. LEVY S., TEMPE J.-L., CAUSSADE P. et al. (1984) Stage-related decrease in natural killer activity in untreated patients with mycosis fungoides. Cancer Immunol Immunother 18, 138.
14. DU VIVIER A., HARPER R., VONDERHEID E.C. & SCOTT E.V. (1978) Lymphocyte transformation in patients with staged mycosis fungoides and Sèzary syndrome. Cancer 42, 209.
15. HEALD P.W. & EDELSON R.L. (1993) Lymphoma, pseudolymphoma and related conditions,. In: Dermatology in General Medicin (ed. T.B. Fitzpatrick), 4th edn, p. 1285. McGraw-Hill, New York.
16. VOWELS B.R., CASSIN M., VONDERHEID E.C. & ROOK A.H. (1992) Aberrant cytokine production by Sèzary syndrome patients: cytokine secretion pattern resembles murine Th2 cells. J Invest Dermatol 9, 90.
17. VOWELS B.R., LESSIN S.R., CASSIN M. et al. (1994) Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma. J Invest Dermatol 103, 669.
18. LESSIN S.R., VOWELS B.R. & ROOK A.H. (1995) Th2 cytokine profile in cutaneous T-cell lymphoma. J Invest Dermatol 105, 855.
19. DUMMER R., KOHL O., GILLESSIEN J. et al. (1993) Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T-cell lymphoma. Arch Dermatol 129, 433.
20. WOOD G.S., TUNG R.M., HAEFFNER A.C. et al. (1994) Detection of clonal T-cell receptor y gene rearrangements in early mycosis fungoides/Sézary Syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE). J Invest Dermatol 103, 34.
21. BAKELS V., VAN OOSTVEEN J.W., GORDIJN R.L.J. et al. (1992) Frequency and prognostic significance of clonal T-cell receptor β-gene rearrangements in the peripheral blood of patients with mycosis fungoides. Arch Dermatol 92, 1602.
22. EORTC/BMFT Cutaneous lymphoma Project Group (1987) Classification and Staging of Cutaneous Lymphoma. A European Concept.
23. LANFORD M.P., WEIGENT D.A., STANTON G.J. & BARON S. (1981) Virus plaque reduction assay for interferon: microplaque and regular macrophage reduction assay. In: Methods in Enzymology (ed. S. Pestka), Vol. 78A, p. 339. Academic Press, New York.
24. MOSSMAN T.R. & COFFMAN R.L. (1989) TH1 and TH2 cells: different pattern of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7, 145.
25. ROOK A.H., KUBIN M., CASSIN M. et al. (1995) IL-12 reverses cytokine and immune abnormalities in Sèzary syndrome. J Immunol 154, 1491.
26. KAWAKAMI Y., CUSTER M.C., ROSENBERG S.A. & LOTZE M.T. (1989) IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes. J Immunol 142, 3452.
27. D'ANDREA A., ASTE-AMEZAGA M., VALIANTE N.M., MA X., KUBIN M. & TRINCHIERI G. (1993) Interleukin-10 inhibits human lymphocyte IFN-γ production by suppressing natural killer cell stimulatory factor/interleukin 12 synthesis in accessory cells. J Exp Med 178, 1041.
28. KOBAYASHI M., FITZ L., HEWICK M. et al. (1989) Identification and purification of suppressing natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 170, 827.
29. + T lymphocytes. J Immunol 151, 2444.
30. MANETTI R., PARRONCHI P., GIUDIZI M.G. et al. (1993) Natural killer cell stimulatory factor (IL 12) induces Th1-type specific immune responses and inhibits the development of IL4-producmg Th cells. J Exp Med 177, 1199.
31. CHAN S.H., PERUSSIA B., GUPTA J.W. et al. (1991) Induction of INF-γ production by NK cell stimulatory factor (NKSF): characterisation of the responder cells and synergy with other inductors. J Exp Med 173, 869.
32. SYPEK J.P., CHUNG C.L., MAYOR S.E.H. et al. (1993) Resolution of cutaneous leishmaniasis: IL12 initiates a protective T helper type 1 immune response. J Exp Med 177, 1797.